About Lymphoma | Advocacy | Art | CAM | Clinical trials | Doctors - Experts - Centers | Guidelines at Diagnosis | News
Risk Factors | Side Effects | Statistics | Support | Symptoms | Tests | Treatments | Types of Lymphoma

Search Site         Guidelines at Diagnosis | About Clinical Trials            How to Help!

Patients Against Lymphoma

 

Clinical Trials > By Treatment type > Antiangiogenesis agents

 

Last update: 12/08/2011

 

  • Bevacizumab (anti-VEGF) 

    TOPIC SEARCH: Mechanisms PubMed 

     

  • Cilengitide (EMD 121974)

    TOPIC SEARCH: Mechanisms PubMed 

     

  • CC-5013 (Lenalidomide/ Revlimid)

    TOPIC SEARCH: Mechanisms PubMed 
     

  • FR901228

    TOPIC SEARCH: Mechanisms PubMed 

     

  • MS-275

    TOPIC SEARCH: Mechanisms PubMed 
     
     

  • Sorafenib (BAY 43-9006)

    TOPIC SEARCH: Mechanisms PubMed 

     

  • Thalidomide  

    TOPIC SEARCH: Mechanisms PubMed 
     

 

 

 
Disclaimer:  The information on Lymphomation.org is not intended to be a substitute for 
professional medical advice or to replace your relationship with a physician.
For all medical concerns,  you should always consult your doctor. 
Patients Against Lymphoma, Copyright © 2004,  All Rights Reserved.